Formaldehyde

Formaldehyde

SCHEMBL2160216

[2H]C=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formaldehyde SCHEMBL3378043 0.93
Formaldehyde SCHEMBL7855283 0.93
Formaldehyde SCHEMBL5831198 0.83
Formaldehyde SCHEMBL16922655 0.72
Formaldehyde SCHEMBL268 0.71
Formaldehyde SCHEMBL3907789 0.71
Formaldehyde SCHEMBL6977718 0.71
Formaldehyde SCHEMBL13582711 0.71
Formaldehyde SCHEMBL12190180 0.71
Formaldehyde SCHEMBL1347887 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4006074-B1 ROSIN-MODIFIED PHENOLIC RESIN, LITHOGRAPHIC PRINTING INK, AND PRINTED MATTER ARTIENCE CO LTD (JP) 2025-11-12 EP claimed
CN-111936144-B JAK inhibitors 廖细斌 2023-12-22 CN claimed
CN-116018222-A Filament composition containing metal powder for 3D printer and filament using the same 可隆塑胶株式会社 2023-04-25 CN claimed
CN-114599466-A Binder composition for metal powder injection molding 可隆塑胶株式会社 2022-06-07 CN claimed
WO-2014055603-A1 PROCESS FOR THE PREPARATION OF AN HIV INTEGRASE INHIBITOR GILEAD SCIENCES, INC. (US) 2014-04-10 WO claimed
EP-2694479-A1 PROCESS FOR THE PREPARATION OF AN HIV INTEGRASE INHIBITOR Gilead Sciences, Inc. (US) 2014-02-12 EP claimed
WO-2012138670-A1 PROCESS FOR THE PREPARATION OF AN HIV INTEGRASE INHIBITOR GILEAD SCIENCES, INC. (US) 2012-10-11 WO claimed
EP-1838653-B1 NOVEL TRIMETHYLCYCLODODECATRIENE DERIVATIVES, USE THEREOF, AND PERFUMED PRODUCTS CONTAINING THE SAME MANE FILS V (FR) 2010-08-04 EP claimed
US-20080139446-A1 Novel Trimethylcyclodoecatriene Derivatives, Use Thereof And Perfumed Products Containing The Same V. MANE FILS (FR) 2008-06-12 US claimed
CN-101119958-A Novel trimethylcyclododecatriene derivatives, use thereof, and perfumed products containing the same MANE FILS V (FR) 2008-02-06 CN claimed
EP-4665733-A1 AMINO-SUBSTITUTED PYRROLOTRIAZINE DERIVATIVES AS INHIBITORS OF SGK1 Bristol-Myers Squibb Company (US) 2025-12-24 EP disclosed
EP-4658644-A1 2-(PYRIDAZIN-3-YL)-5-(TRIFLUOROMETHYL)PHENOLS AS NLRP3 INHIBITORS Janssen Pharmaceutica NV (BE) 2025-12-10 EP disclosed
US-20250325512-A1 Neurodegenerative Disorders And Muscle Diseases Implicating Pufas BIOJIVA LLC (US) 2025-10-23 US disclosed
EP-4534478-A1 MESOPOROUS HIGHLY CONDUCTIVE CARBON-AEROGEL COMPOSITES BASED ON CHITOSAN Deutsches Zentrum für Luft- und Raumfahrt e.V. (DE) 2025-04-09 EP disclosed
WO-2025026845-A1 PROCESS FOR PREPARING LEATHER INCLUDING BIOPOLYMER PARTICLES TFL LEDERTECHNIK GMBH (DE) 2025-02-06 WO disclosed
US-5344990-A Process for the preparation of a renin inhibiting compound ABBOTT LABORATORIES (US) 1994-09-06 US disclosed
US-4800012-A Electrochemical process for the replacement of halogen atoms in an organic compound HOECHST AKTIENGESELLSCHAFT (DE) 1989-01-24 US disclosed
EP-0091181-B1 AROYL PYRROLIZINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BEECHAM GROUP PLC (GB) 1986-12-17 EP disclosed
EP-0128175-A1 TRICYCLO AD5,2,1,0?2,6 BDDECAN DERIVATIVES WITH FUNCTIONALIZED LATERAL CHAIN, PRODUCTION AND UTILIZATION THEREOF AS PERFUMES Dragoco Gerberding & Co. GmbH (DE) 1984-12-19 EP disclosed
WO-1984002338-A1 TRICYCLO AD5,2,1,02,6 BDDECAN DERIVATIVES WITH FUNCTIONALIZED LATERAL CHAIN, PRODUCTION AND UTILIZATION THEREOF AS PERFUMES DRAGOCO GERBERDING CO GMBH (DE) 1984-06-21 WO disclosed